Involvement of glycation and oxidative stress in diabetic macroangiopathy

N Taniguchi1, H Kaneto, M Asahi

  • 1Department of Biochemistry, Osaka University Medical School, Japan.

Diabetes
|July 1, 1996
PubMed

Insights

Diabetic conditions increase oxidative stress via the Maillard reaction, impairing antioxidant enzymes. This oxidative stress promotes smooth muscle cell proliferation and diabetic macroangiopathy by enhancing gene expression of heparin-binding epidermal growth factor-like growth factor (HB-EGF).

Area of Science:

  • Biochemistry and Molecular Biology
  • Diabetic Complications Research
  • Cardiovascular Pathogenesis

Background:

  • Diabetic conditions exacerbate oxidative stress through the Maillard reaction, decreasing antioxidant enzyme activity (e.g., Cu,Zn-superoxide dismutase).
  • Oxidative stress damages cellular components and contributes to diabetic complications, notably macroangiopathy.
  • Smooth muscle cell (SMC) proliferation, driven by growth factors like platelet-derived growth factor (PDGF) and heparin-binding epidermal growth factor-like growth factor (HB-EGF), is implicated in macroangiopathy progression.

Purpose of the Study:

  • To investigate the role of glycation reactions and oxidative stress in the pathogenesis of diabetic macroangiopathy.
  • To elucidate the specific mechanisms by which 3-deoxyglucosone (3-DG) influences gene expression of growth factors involved in SMC proliferation.

Main Methods:

  • Analysis of the Maillard reaction's impact on reactive oxygen species (ROS) production and antioxidant enzyme activity in diabetic conditions.
  • Assessment of oxidative stress markers and their correlation with DNA, lipid, and protein damage.
  • Investigation of growth factor production by SMCs, focusing on PDGF and HB-EGF.
  • Examination of the transcriptional regulation of HB-EGF by 3-DG and the role of ROS in this induction.

Main Results:

  • Diabetic conditions lead to increased oxidative stress and reduced antioxidant enzyme activity.
  • Oxidative stress is linked to cellular damage and the progression of macroangiopathy.
  • HB-EGF, a potent mitogen for SMCs, is transcriptionally regulated by 3-DG, a key glycation intermediate.
  • The induction of HB-EGF by 3-DG appears to be mediated by ROS generated from 3-DG.

Conclusions:

  • Glycation reactions, particularly involving 3-DG, significantly contribute to diabetic macroangiopathy pathogenesis.
  • Enhanced gene expression of HB-EGF, triggered by 3-DG-induced oxidative stress, plays a crucial role in SMC proliferation and macroangiopathy progression in diabetes.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...